Literature DB >> 19371477

Salvage therapy for prostate cancer recurrence after radiation therapy.

Jared M Cox1, J Erik Busby.   

Abstract

Radiotherapy has been successful in treating localized prostate cancer; however, a subset of patients will experience disease recurrence. Determination of the recurrence location must be made using pretreatment and posttreatment clinical variables, imaging, and postradiotherapy biopsy. Patients presumed to have local-only recurrence, optimal clinical risk factors, and an extended life expectancy may be considered for salvage local treatment. Current options include salvage surgery, cryoablation, and brachytherapy. Although they are associated with higher morbidity than primary therapy, salvage treatments can be effective and can still provide patients with a good oncologic and functional outcome. As these modalities continue to improve and patient selection is optimized, better results will evolve.

Entities:  

Mesh:

Year:  2009        PMID: 19371477     DOI: 10.1007/s11934-009-0034-7

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  49 in total

1.  PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.

Authors:  Michael E Ray; Howard D Thames; Larry B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-29       Impact factor: 7.038

2.  Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.

Authors:  Brian Lee; Katsuto Shinohara; Vivian Weinberg; Alexander R Gottschalk; Jean Pouliot; Mack Roach; I-Chow Hsu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

3.  12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.

Authors:  Louis Potters; Carol Morgenstern; Emil Calugaru; Paul Fearn; Anup Jassal; Joseph Presser; Edward Mullen
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

Review 4.  Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer.

Authors:  Frank A Vicini; Carlos Vargas; Anthony Abner; Larry Kestin; Eric Horwitz; Alvaro Martinez
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

5.  Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.

Authors:  William U Shipley; Michelle Desilvio; Michael V Pilepich; Mack Roach; Harvey B Wolkov; William T Sause; Philip Rubin; Colleen A Lawton
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-19       Impact factor: 7.038

6.  The efficacy and complications of salvage cryotherapy of the prostate.

Authors:  L L Pisters; A C von Eschenbach; S M Scott; D A Swanson; C P Dinney; C A Pettaway; R J Babaian
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

7.  Salvage brachytherapy for localized prostate cancer after radiotherapy failure.

Authors:  G L Grado; J M Collins; J S Kriegshauser; C S Balch; M M Grado; G P Swanson; T R Larson; M M Wilkes; R J Navickis
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

Review 8.  Rising PSA in nonmetastatic prostate cancer.

Authors:  Judd W Moul; Lionel L Bañez; Stephen J Freedland
Journal:  Oncology (Williston Park)       Date:  2007-11       Impact factor: 2.990

9.  Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

Authors:  Patrick A Kupelian; Louis Potters; Deepak Khuntia; Jay P Ciezki; Chandana A Reddy; Alwyn M Reuther; Thomas P Carlson; Eric A Klein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

10.  Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up.

Authors:  Duke K Bahn; Fred Lee; Paul Silverman; Eric Bahn; Robert Badalament; Anil Kumar; Jeffrey Greski; John C Rewcastle
Journal:  Clin Prostate Cancer       Date:  2003-09
View more
  3 in total

Review 1.  High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer.

Authors:  A Challapalli; E Jones; C Harvey; G O Hellawell; S A Mangar
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

2.  Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer.

Authors:  Imran Ahmad; Gabriela Kalna; Mohamed Ismail; Fiona Birrell; Sue Asterling; Elaine McCartney; Damien Greene; John Davies; Hing Y Leung
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

3.  Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity.

Authors:  Iván Henríquez; Gemma Sancho; Asunción Hervás; Benjamin Guix; Joan Pera; Cristina Gutierrez; Oscar Abuchaibe; Rafael Martínez-Monge; Alejandro Tormo; Alfredo Polo
Journal:  Radiat Oncol       Date:  2014-04-30       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.